Jennifer Robertson, PharmD, BCPS, FASHP

Jennifer Robertson, PharmD, BCPS, FASHP

  • Medication-Use Safety and Policy Residency Director
  • Director, Medication Outcomes and Safety

Board Certification(s)

  • BCPS

Education

  • PharmD – University of Tennessee College of Pharmacy, Memphis, Tennessee

Post-Graduate Training

  • Specialty Residency in Drug Information - Methodist Healthcare, Memphis, Tennessee

Focused Area of Practice

  • Medication Use Policy
  • Medication Safety

Research Interests

  • Medication Event Prevention
  • Clinical Decision Support/Alert Fatigue

St. Jude Committee Service

  • Pharmacy and Therapeutics Committee
  • Medication Use Safety Team
  • Patient Safety Event Evaluation Team
  • Quality Patient Safety Council

Pharmacy Organizations/Committee Service

  • American Society of Health System Pharmacists
    • Council on Education and Workforce Development, 2021-present
    • Committee on Nominations, Section of Inpatient Care Practitioners, 2017-present
  • Tennessee Pharmacists Association
    • Programming and Education Committee, Tennessee Society of Health-System Pharmacists (TSHP), 2020-present
    • Residency Committee, TSHP, 2023
  • Medication Safety Officers Society
  • Mid-South College of Clinical Pharmacy

Related Topics

Selected Publications

Daniels CC, Burlison JD, Baker DK, Robertson J, et al. Optimizing drug-drug interaction alerts using a multidimensional approach. Pediatrics. 2019; 143(3): e20174111.

Billstein-Leber M, Carrillo JD, Cassano AT, Moline K, Robertson, JJ. ASHP Guidelines on Preventing Medication Errors in Hospitals. Am J Health Syst Pharm. 2018; 75 (19): 1493-1517.

Burlison JD, McDaniel RB, Baker DK, Hasan M, Robertson JJ, Howard SC, Hoffman JM. Using EHR data to detect prescribing errors in rapidly discontinued medication orders. Appl Clin Inform. 2018; 9: 82-88.

McDaniel RB, Burlison JD, Baker DK, Hasan M, Robertson J, Hartford C, et al. Alert dwell time: introduction of a measure to evaluate interruptive clinical decision support alerts. J Am Med Inform Assoc. 2015 Oct 24. http://dx.doi.org/10.1093/jamia/ocv144 [Epub ahead of print].

Call RJ, Burlison JD, Robertson JJ, Scott JR, Baker DK, Rossi MG, Howard SC, Hoffman JM. Adverse drug event detection in pediatric oncology and hematology patients: Using medication triggers to identify patient harm in a specialized pediatric patient population. J Pediatr 165(3):447-52, 2014.

Last update: September 2023

Close
Close